• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析配体识别的结构基础:溶血磷脂酸受体 LPA.

Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA.

机构信息

Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan.

Global Research Cluster, RIKEN, Wako, Saitama 351-0198, Japan.

出版信息

Nature. 2017 Aug 17;548(7667):356-360. doi: 10.1038/nature23448. Epub 2017 Aug 9.

DOI:10.1038/nature23448
PMID:28792932
Abstract

Lysophosphatidic acid (LPA) is a bioactive lipid composed of a phosphate group, a glycerol backbone, and a single acyl chain that varies in length and saturation. LPA activates six class A G-protein-coupled receptors to provoke various cellular reactions. Because LPA signalling has been implicated in cancer and fibrosis, the LPA receptors are regarded as promising drug targets. The six LPA receptors are subdivided into the endothelial differentiation gene (EDG) family (LPA-LPA) and the phylogenetically distant non-EDG family (LPA-LPA). The structure of LPA has enhanced our understanding of the EDG family of LPA receptors. By contrast, the functional and pharmacological characteristics of the non-EDG family of LPA receptors have remained unknown, owing to the lack of structural information. Although the non-EDG LPA receptors share sequence similarity with the P2Y family of nucleotide receptors, the LPA recognition mechanism cannot be deduced from the P2Y and P2Y structures because of the large differences in the chemical structures of their ligands. Here we determine the 3.2 Å crystal structure of LPA, the gene deletion of which is responsible for congenital hair loss, to clarify the ligand recognition mechanism of the non-EDG family of LPA receptors. Notably, the ligand-binding pocket of LPA is laterally open towards the membrane, and the acyl chain of the lipid used for the crystallization is bound within this pocket, indicating the binding mode of the LPA acyl chain. Docking and mutagenesis analyses also indicated that the conserved positively charged residues within the central cavity recognize the phosphate head group of LPA by inducing an inward shift of transmembrane helices 6 and 7, suggesting that the receptor activation is triggered by this conformational rearrangement.

摘要

溶血磷脂酸(LPA)是一种由磷酸基团、甘油骨架和一个长短和饱和度不一的酰基链组成的生物活性脂质。LPA 通过激活六个 A 类 G 蛋白偶联受体来引发各种细胞反应。由于 LPA 信号转导与癌症和纤维化有关,LPA 受体被认为是有前途的药物靶点。这六个 LPA 受体被分为内皮分化基因(EDG)家族(LPA-LPA)和系统发育上较远的非 EDG 家族(LPA-LPA)。LPA 的结构增强了我们对 EDG 家族 LPA 受体的理解。相比之下,由于缺乏结构信息,非 EDG 家族 LPA 受体的功能和药理学特征仍然未知。尽管非 EDG LPA 受体与核苷酸受体的 P2Y 家族具有序列相似性,但由于其配体的化学结构差异很大,无法从 P2Y 和 P2Y 结构推导出 LPA 识别机制。在这里,我们确定了负责先天性脱发的基因缺失的 LPA 的 3.2Å 晶体结构,以阐明非 EDG 家族 LPA 受体的配体识别机制。值得注意的是,LPA 的配体结合口袋向膜的侧面敞开,用于结晶的脂质的酰基链结合在这个口袋内,表明了 LPA 酰基链的结合模式。对接和突变分析也表明,中央腔中保守的带正电荷残基通过诱导跨膜螺旋 6 和 7 的向内移位来识别 LPA 的磷酸头基团,这表明受体的激活是由这种构象重排触发的。

相似文献

1
Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA.解析配体识别的结构基础:溶血磷脂酸受体 LPA.
Nature. 2017 Aug 17;548(7667):356-360. doi: 10.1038/nature23448. Epub 2017 Aug 9.
2
Non-Edg family LPA receptors: the cutting edge of LPA research.非 Edg 家族 LPA 受体:LPA 研究的前沿。
J Biochem. 2011 Sep;150(3):223-32. doi: 10.1093/jb/mvr087. Epub 2011 Jul 11.
3
Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.关于溶血磷脂酸(LPA)受体4/LPA(4)/嘌呤能受体P2Y9/p2y(9)/G蛋白偶联受体23(GPR23)的三维结构及溶血磷脂酸结合特性:一项同源建模研究
J Mol Graph Model. 2009 Aug;28(1):70-9. doi: 10.1016/j.jmgm.2009.04.004. Epub 2009 Apr 19.
4
Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.鉴定p2y9/GPR23为一种新型的溶血磷脂酸G蛋白偶联受体,其结构与Edg家族不同。
J Biol Chem. 2003 Jul 11;278(28):25600-6. doi: 10.1074/jbc.M302648200. Epub 2003 Apr 30.
5
Lysophosphatidic acid (LPA) signaling via LPA and LPA negatively regulates cell motile activities of colon cancer cells.溶血磷脂酸(LPA)通过LPA信号通路对结肠癌细胞的细胞运动活性起负向调节作用。
Biochem Biophys Res Commun. 2017 Jan 29;483(1):652-657. doi: 10.1016/j.bbrc.2016.12.088. Epub 2016 Dec 18.
6
Non-Edg family lysophosphatidic acid (LPA) receptors.非Edg家族溶血磷脂酸(LPA)受体。
Prostaglandins Other Lipid Mediat. 2009 Sep;89(3-4):57-65. doi: 10.1016/j.prostaglandins.2009.06.001. Epub 2009 Jun 12.
7
Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.Ki16425,一种针对EDG家族溶血磷脂酸受体的亚型选择性拮抗剂。
Mol Pharmacol. 2003 Oct;64(4):994-1005. doi: 10.1124/mol.64.4.994.
8
Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells.比较 LPA 对人肺内皮细胞屏障功能的差异影响。
Microvasc Res. 2013 Jan;85:59-67. doi: 10.1016/j.mvr.2012.10.004. Epub 2012 Oct 16.
9
The role of lysophosphatidic acid in the physiology and pathology of the skin.溶血磷脂酸在皮肤生理和病理中的作用。
Life Sci. 2019 Mar 1;220:194-200. doi: 10.1016/j.lfs.2018.12.040. Epub 2018 Dec 22.
10
Elucidating the binding mechanism of LPA species and analogs in an LPA receptor homology model.在溶血磷脂酸(LPA)受体同源模型中阐明LPA种类及其类似物的结合机制。
J Mol Graph Model. 2022 Nov;116:108274. doi: 10.1016/j.jmgm.2022.108274. Epub 2022 Jul 16.

引用本文的文献

1
Modulation of lipid metabolism by exercise: exploring its potential as a therapeutic target in cancer endocrinology.运动对脂质代谢的调节作用:探索其作为癌症内分泌学治疗靶点的潜力。
Front Endocrinol (Lausanne). 2025 May 23;16:1580559. doi: 10.3389/fendo.2025.1580559. eCollection 2025.
2
LPAR6 Inhibits the Progression of Hepatocellular Carcinoma (HCC) by Suppressing the Nuclear Translocation of YAP/TAZ.LPAR6通过抑制YAP/TAZ的核转位来抑制肝细胞癌(HCC)的进展。
Int J Mol Sci. 2025 Apr 29;26(9):4205. doi: 10.3390/ijms26094205.
3
Possible Involvement of Lysophospholipids in Severe Asthma as Novel Lipid Mediators.

本文引用的文献

1
Conformational Profiling of the AT1 Angiotensin II Receptor Reflects Biased Agonism, G Protein Coupling, and Cellular Context.AT1血管紧张素II受体的构象分析反映了偏向性激动、G蛋白偶联和细胞环境。
J Biol Chem. 2017 Mar 31;292(13):5443-5456. doi: 10.1074/jbc.M116.763854. Epub 2017 Feb 17.
2
Activation mechanism of endothelin ET receptor by endothelin-1.内皮素-1 激活内皮素 ET 受体的机制。
Nature. 2016 Sep 15;537(7620):363-368. doi: 10.1038/nature19319. Epub 2016 Sep 5.
3
PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions.
溶血磷脂作为新型脂质介质可能参与重度哮喘的发病过程。
Biomolecules. 2025 Jan 27;15(2):182. doi: 10.3390/biom15020182.
4
Molecular mechanism of ligand recognition and activation of lysophosphatidic acid receptor LPAR6.溶血磷脂酸受体LPAR6的配体识别与激活的分子机制
Proc Natl Acad Sci U S A. 2025 Jan 28;122(4):e2415426122. doi: 10.1073/pnas.2415426122. Epub 2025 Jan 23.
5
Structural mechanisms of potent lysophosphatidic acid receptor 1 activation by nonlipid basic agonists.非脂类碱性激动剂激活强效溶血磷脂酸受体 1 的结构机制。
Commun Biol. 2024 Nov 6;7(1):1444. doi: 10.1038/s42003-024-07152-y.
6
From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling.从经典到替代的 2-花生四烯酸甘油合成途径:内源性大麻素和溶血磷脂信号交汇点的 AlterAGs。
Molecules. 2024 Aug 4;29(15):3694. doi: 10.3390/molecules29153694.
7
Bitter taste receptor activation by cholesterol and an intracellular tastant.胆固醇和细胞内味觉配体激活苦味受体
Nature. 2024 Apr;628(8008):664-671. doi: 10.1038/s41586-024-07253-y. Epub 2024 Apr 10.
8
Linking the Autotaxin-LPA Axis to Medicinal Cannabis and the Endocannabinoid System.将 Autotaxin-LPA 轴与医用大麻和内源性大麻素系统联系起来。
Int J Mol Sci. 2024 Mar 12;25(6):3212. doi: 10.3390/ijms25063212.
9
Structural basis for lysophosphatidylserine recognition by GPR34.GPR34 识别溶血磷脂酰丝氨酸的结构基础。
Nat Commun. 2024 Feb 7;15(1):902. doi: 10.1038/s41467-024-45046-z.
10
Involvement of Lysophospholipids in Pulmonary Vascular Functions and Diseases.溶血磷脂在肺血管功能及疾病中的作用
Biomedicines. 2024 Jan 8;12(1):124. doi: 10.3390/biomedicines12010124.
PROPKA3:经验 pKa 预测中内部残基和表面残基的一致处理。
J Chem Theory Comput. 2011 Feb 8;7(2):525-37. doi: 10.1021/ct100578z. Epub 2011 Jan 6.
4
Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1.拮抗剂结合的人溶血磷脂酸受体1的晶体结构
Cell. 2015 Jun 18;161(7):1633-43. doi: 10.1016/j.cell.2015.06.002.
5
The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells.溶血磷脂酸受体LPA4调节骨髓基质细胞的造血支持活性。
Sci Rep. 2015 Jun 19;5:11410. doi: 10.1038/srep11410.
6
Analysis of unique mutations in the LPAR6 gene identified in a Japanese family with autosomal recessive woolly hair/hypotrichosis: Establishment of a useful assay system for LPA6.对一个患常染色体隐性遗传性羊毛状发/毛发稀少症的日本家庭中鉴定出的LPAR6基因独特突变的分析:LPA6实用检测系统的建立。
J Dermatol Sci. 2015 Jun;78(3):197-205. doi: 10.1016/j.jdermsci.2015.03.006. Epub 2015 Mar 18.
7
Two disparate ligand-binding sites in the human P2Y1 receptor.人类P2Y1受体中的两个不同配体结合位点。
Nature. 2015 Apr 16;520(7547):317-21. doi: 10.1038/nature14287. Epub 2015 Mar 30.
8
LSD1 controls metastasis of androgen-independent prostate cancer cells through PXN and LPAR6.LSD1 通过 PXN 和 LPAR6 控制雄激素非依赖性前列腺癌细胞的转移。
Oncogenesis. 2014 Oct 6;3(10):e120. doi: 10.1038/oncsis.2014.34.
9
Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS/MS.采用液相色谱-串联质谱法对生物样品中的2-酰基-1-溶血磷脂和1-酰基-2-溶血磷脂进行分离和定量分析。
J Lipid Res. 2014 Oct;55(10):2178-92. doi: 10.1194/jlr.D048439. Epub 2014 Aug 11.
10
Agonist-bound structure of the human P2Y12 receptor.人源 P2Y12 受体激动剂结合结构。
Nature. 2014 May 1;509(7498):119-22. doi: 10.1038/nature13288.